$ISIS Company News 5 companies that will benefit from

New Post Public Reply Private Reply Replies (0) Message Board

Aug 24, 2014 at 1:00 PM

$ISIS Company News

5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 9:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 11:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 1:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 1:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 12:59 p.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 11:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 3:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 10:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 11:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 3:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 11:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 5:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 6:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 7:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 7:01 a.m. June 3, 2013 - Jeff Reeves
S&P 500 holds the 50-day average — barely 11:41 a.m. April 18, 2013 - Michael Ashbaugh
Biogen inks drug-development deal with Isis 3:06 p.m. Dec. 10, 2012 - MarketWatch.com

Hottest Healthcare Stocks Now – PRGO WX ISIS TARO 8:30 a.m. Aug. 14, 2014 - InvestorPlace.com
UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT 10:34 a.m. Aug. 12, 2014 - benzinga.com
Alnylam Pharmaceuticals Has Plenty On Its Plate 10:36 a.m. Aug. 9, 2014 - Seeking Alpha
Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog 9:10 a.m. Aug. 7, 2014 - Zacks.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 7, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – CBPO ISIS HAE LPNT 2:00 p.m. Aug. 5, 2014 - InvestorPlace.com
Company News for August 05, 2014 - Corporate Summary 10:10 a.m. Aug. 5, 2014 - Zacks.com
ISIS Pharmaceuticals' (ISIS) CEO Stan Crooke on Q2 2014 Results - Earnings Call Transcript 4:24 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: ISIS PHARMACEUTICALS INC 3:29 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biggest Movers in Healthcare Stocks Now – ALNY ISIS INCY HTWR 1:15 p.m. Aug. 4, 2014 - InvestorPlace.com
Insider Trading Alert - GPN, UHS And ISIS Traded By Insiders 10:30 a.m. Aug. 4, 2014 - TheStreet.com
Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential 7:36 a.m. Aug. 4, 2014 - Seeking Alpha
Isis set for milestone payment from Biogen 8:32 a.m. Aug. 1, 2014 - Seeking Alpha
Cramer's Lightning Round - 6 Biotech Picks (7/30/14) 6:35 a.m. July 31, 2014 - Seeking Alpha
ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners 10:52 a.m. July 25, 2014 - Seeking Alpha
Isis Pharma Initiates Phase II Study on ISIS-APO(a) - Analyst Blog 6:50 p.m. July 21, 2014 - Zacks.com
Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients With High Lp(a) 6:01 a.m. July 17, 2014 - benzinga.com
Cramer's Lightning Round - BioMarin Deserves To Be Higher (7/14/14) 6:04 a.m. July 15, 2014 - Seeking Alpha
Cramer's Mad Money - Dean Foods Will Do Your Portfolio Good (7/10/14) 6:01 a.m. July 11, 2014 - Seeking Alpha
Post-Market Laggard: Isis Pharmaceuticals (ISIS) 7:56 p.m. July 7, 2014 - TheStreet.com

Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 7:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 7:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 7:00 a.m. July 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a) 7:00 a.m. July 17, 2014 - PR Newswire - PRF
Critical Alerts For Cninsure, Freeport-McMoRan, Level 3 Communications, Electronic Arts, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 16, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx 7:00 a.m. July 16, 2014 - PR Newswire - PRF
Type 2 Diabetes Global Clinical Trials Review, H1, 2014 3:31 p.m. July 15, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program 7:00 a.m. July 2, 2014 - PR Newswire - PRF
Critical Alerts For General Electric, Deere, Isis Pharmaceuticals, Expedia, and Sears Holdings Released By InvestorsObserver 9:31 a.m. June 26, 2014 - PR Newswire - PRF
Global Diabetic Retinopathy Market 2014-2018 12:22 p.m. June 25, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing ISIS-TTR Rx 7:00 a.m. June 24, 2014 - PR Newswire - PRF
Collaborations, FDA Clearances, and Technical Updates - Analyst Notes on Isis Pharmaceuticals, DexCom, Theravance Biopharma, Intrexon and Alere 5:30 a.m. June 19, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Quarterly Changes to the NASDAQ Q-50 Index 7:15 a.m. June 16, 2014 - GlobeNewswire
Isis Pharmaceuticals Reports Final Phase 2 Data on ISIS-GCGR RX Showing Significant Reduction in HbA1c in Patients with Type 2 Diabetes 7:00 a.m. June 16, 2014 - PR Newswire - PRF
Anticipated Approval of Three New Therapies Through 2023 Will Expand Treatment Options for the Control and Relief of Motor Symptoms in Huntington's Disease 10:00 a.m. June 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 2014 Wells Fargo Healthcare Conference 7:00 a.m. June 12, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Protecting Teeth: Insights from Endodontist Dr. Joubert

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...